Suppr超能文献

预测心脏移植受者短期死亡率的心脏供体风险因素:器官共享联合网络数据库分析

Cardiac Donor Risk Factors Predictive of Short-Term Heart Transplant Recipient Mortality: An Analysis of the United Network for Organ Sharing Database.

作者信息

Sorabella R A, Guglielmetti L, Kantor A, Castillero E, Takayama H, Schulze P C, Mancini D, Naka Y, George I

机构信息

Division of Cardiothoracic Surgery, New York Presbyterian Hospital, Columbia University College of Physicians and Surgeons, New York, New York, USA.

Division of Cardiology, New York Presbyterian Hospital, Columbia University College of Physicians and Surgeons, New York, New York, USA.

出版信息

Transplant Proc. 2015 Dec;47(10):2944-51. doi: 10.1016/j.transproceed.2015.10.021.

Abstract

INTRODUCTION

To address the shortage of donor hearts for transplantation, there is significant interest in liberalizing donor acceptance criteria. Therefore, the aim of this study was to evaluate cardiac donor characteristics from the United Network for Organ Sharing (UNOS) database to determine their impact on posttransplantation recipient outcomes.

METHODS

Adult (≥18 years) patients undergoing heart transplantation from July 1, 2004, to December 31, 2012, in the UNOS Standard Transplant Analysis and Research (STAR) database were reviewed. Patients were stratified by 1-year posttransplantation status; survivors (group S, n = 13,643) and patients who died or underwent cardiac retransplantation at 1-year follow-up (group NS/R = 1785). Thirty-three specific donor variables were collected for each recipient, and independent donor predictors of recipient death or retransplantation at 1 year were determined using multivariable logistic regression analysis.

RESULTS

Overall 1-year survival for the entire cohort was 88.4%. Mean donor age was 31.5 ± 11.9 years, and 72% were male. On multivariable logistic regression analysis, donor age >40 years (odds ratio [OR] 1.44, 95% confidence interval [CI] 1.27 to 1.64), graft ischemic time >3 hours (OR 1.32, 1.16 to 1.51), and the use of cardioplegia (OR 1.17, 1.01 to 1.35) or Celsior (OR 1.21, 1.06 to 1.38) preservative solution were significant predictors of recipient death or retransplantation at 1 year posttransplantation. Male donor sex (OR 0.83, 0.74 to 0.93) and the use of antihypertensive agents (OR 0.88, 0.77 to 1.00) or insulin (OR 0.84, 0.76 to 0.94) were protective from adverse outcomes at 1 year.

CONCLUSIONS

These data suggest that donors who are older, female, or have a long projected ischemic time pose greater risk to heart transplant recipients in the short term. Additionally, certain components of donor management protocols, including antihypertensive and insulin administration, may be protective to recipients.

摘要

引言

为解决心脏移植供体心脏短缺的问题,放宽供体接受标准引起了广泛关注。因此,本研究旨在评估器官共享联合网络(UNOS)数据库中的心脏供体特征,以确定其对移植后受体结局的影响。

方法

回顾了2004年7月1日至2012年12月31日在UNOS标准移植分析与研究(STAR)数据库中接受心脏移植的成年(≥18岁)患者。根据移植后1年的状态对患者进行分层;存活者(S组,n = 13,643)和在1年随访时死亡或接受心脏再次移植的患者(NS/R组 = 1785)。为每位受体收集了33个特定的供体变量,并使用多变量逻辑回归分析确定了受体在1年时死亡或再次移植的独立供体预测因素。

结果

整个队列的1年总生存率为88.4%。供体平均年龄为31.5±11.9岁,72%为男性。在多变量逻辑回归分析中,供体年龄>40岁(比值比[OR] 1.44,95%置信区间[CI] 1.27至1.64)、移植物缺血时间>3小时(OR 1.32,1.16至1.51)以及使用心脏停搏液(OR 1.17,1.01至1.35)或Celsior(OR 1.21,1.06至1.38)保存液是移植后1年受体死亡或再次移植的显著预测因素。男性供体性别(OR 0.83,0.74至0.93)以及使用抗高血压药物(OR 0.88,0.77至1.00)或胰岛素(OR 0.84,0.76至0.94)可预防1年时的不良结局。

结论

这些数据表明,年龄较大、女性或预计缺血时间较长的供体在短期内对心脏移植受体构成更大风险。此外,供体管理方案的某些组成部分,包括抗高血压药物和胰岛素的使用,可能对受体有保护作用。

相似文献

2
Evaluation of Risk Factors for Heart-Lung Transplant Recipient Outcome: An Analysis of the United Network for Organ Sharing Database.
Circulation. 2019 Oct 8;140(15):1261-1272. doi: 10.1161/CIRCULATIONAHA.119.040682. Epub 2019 Oct 7.
3
Impact of "increased-risk" donor hearts on transplant outcomes: A propensity-matched analysis.
J Thorac Cardiovasc Surg. 2019 Feb;157(2):603-610. doi: 10.1016/j.jtcvs.2018.08.120. Epub 2018 Oct 19.
6
Preoperative risk factors predict survival following cardiac retransplantation: analysis of the United Network for Organ Sharing database.
J Thorac Cardiovasc Surg. 2014 Jun;147(6):1972-7, 1977.e1. doi: 10.1016/j.jtcvs.2014.02.013. Epub 2014 Feb 12.
7
Interaction Between Ischemic Time and Donor Age on Adult Heart Transplant Outcomes in the Modern Era.
Ann Thorac Surg. 2019 Sep;108(3):744-748. doi: 10.1016/j.athoracsur.2019.03.042. Epub 2019 Apr 12.
8
The impact of donor-recipient sex matching on survival after orthotopic heart transplantation: analysis of 18 000 transplants in the modern era.
Circ Heart Fail. 2009 Sep;2(5):401-8. doi: 10.1161/CIRCHEARTFAILURE.108.844183. Epub 2009 Jul 8.
9
Effects of Older Donor Age and Cold Ischemic Time on Long-Term Outcomes of Heart Transplantation.
Tex Heart Inst J. 2018 Feb 1;45(1):17-22. doi: 10.14503/THIJ-16-6178. eCollection 2018 Feb.
10
The Paradoxical Relationship Between Donor Distance and Survival After Heart Transplantation.
Ann Thorac Surg. 2017 May;103(5):1384-1391. doi: 10.1016/j.athoracsur.2017.01.055. Epub 2017 Mar 31.

引用本文的文献

1
Heart donation and transplant recipient survival outcomes from deceased organ donors managed in hospital-based vs independent donor care units.
J Heart Lung Transplant. 2025 Aug;44(8):1225-1236. doi: 10.1016/j.healun.2025.02.1694. Epub 2025 Mar 3.
2
Just a number? Donor age and (lack of) associated reasons for heart offer refusal.
J Heart Lung Transplant. 2024 Nov;43(11):1833-1837. doi: 10.1016/j.healun.2024.07.020. Epub 2024 Jul 31.
4
Disparities in donor heart acceptance between the USA and Europe: clinical implications.
Eur Heart J. 2023 Nov 21;44(44):4665-4674. doi: 10.1093/eurheartj/ehad684.
6
Heart Transplantation With Older Donors: Should There Be an Age Cutoff?
Transplant Proc. 2022 Oct;54(8):2088-2096. doi: 10.1016/j.transproceed.2022.07.004. Epub 2022 Oct 1.
8
Intracerebral bleeding in donors is associated with reduced short-term to midterm survival of heart transplant recipients.
ESC Heart Fail. 2022 Aug;9(4):2419-2427. doi: 10.1002/ehf2.13935. Epub 2022 May 4.
9
Heart Transplant Donor Selection Guidelines: Review and Recommendations.
Curr Cardiol Rep. 2022 Feb;24(2):119-130. doi: 10.1007/s11886-021-01631-y. Epub 2022 Feb 18.
10
Commentary: Planes, trains, and automobiles-Effective use of prolonged ex vivo heart preservation.
J Card Surg. 2021 Jul;36(7):2596-2597. doi: 10.1111/jocs.15520. Epub 2021 Mar 30.

本文引用的文献

1
Outcome after heart transplantation from older donor age: expanding the donor pool.
Eur J Cardiothorac Surg. 2015 Apr;47(4):672-8. doi: 10.1093/ejcts/ezu257. Epub 2014 Jul 9.
3
Heart transplantation outcomes from cardiac arrest-resuscitated donors.
J Heart Lung Transplant. 2013 Nov;32(11):1090-5. doi: 10.1016/j.healun.2013.08.002. Epub 2013 Aug 29.
4
Donor predictors of allograft use and recipient outcomes after heart transplantation.
Circ Heart Fail. 2013 Mar;6(2):300-9. doi: 10.1161/CIRCHEARTFAILURE.112.000165. Epub 2013 Feb 7.
7
Donor scoring system for heart transplantation and the impact on patient survival.
J Heart Lung Transplant. 2012 Apr;31(4):387-97. doi: 10.1016/j.healun.2011.11.005. Epub 2011 Dec 16.
8
Development of a quantitative donor risk index to predict short-term mortality in orthotopic heart transplantation.
J Heart Lung Transplant. 2012 Mar;31(3):266-73. doi: 10.1016/j.healun.2011.10.004. Epub 2011 Nov 16.
9
Impact of high-dose inotropic donor support on early myocardial necrosis and outcomes in cardiac transplantation.
Clin Transplant. 2012 Mar-Apr;26(2):322-7. doi: 10.1111/j.1399-0012.2011.01504.x. Epub 2011 Oct 10.
10
Organ storage with University of Wisconsin solution is associated with improved outcomes after orthotopic heart transplantation.
J Heart Lung Transplant. 2011 Sep;30(9):1033-43. doi: 10.1016/j.healun.2011.05.005. Epub 2011 Jun 17.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验